Evidence map›Paper›PMID 35019757›Full record

ReviewFuture medicinal chemistry2022

Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases.

Daljeet Singh Dhanjal, Parvarish Sharma, Meenu Mehta, Murtaza M Tambuwala, Parteek Prasher, Keshav R Paudel, Gang Liu, Shakti D Shukla, Philip M Hansbro, Dinesh Kumar Chellappan and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in Future medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Daljeet Singh DhanjalSchool of Bioengineering & Biosciences, Lovely Professional University, Phagwara, Punjab, 144411, India.ORCID 0000-0003-4791-7388
Parvarish SharmaSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India.ORCID 0000-0001-8479-3738
Meenu MehtaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia.ORCID 0000-0001-8174-5781
Murtaza M TambuwalaSchool of Pharmacy & Pharmaceutical Sciences, Ulster University, Coleraine, County, Londonderry, BT52 1SA, Northern Ireland, UK.ORCID 0000-0001-8499-9891
Parteek PrasherDepartment of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India.ORCID 0000-0002-9412-9424
Keshav R PaudelCentre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia.ORCID 0000-0002-3591-2080
Gang LiuCentre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia.ORCID 0000-0002-0489-2638
Shakti D ShuklaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia.ORCID 0000-0002-5796-0171
Philip M HansbroCentre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, Australia.ORCID 0000-0002-4741-3035
Dinesh Kumar ChellappanDepartment of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.ORCID 0000-0001-5567-6663
Kamal DuaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia.ORCID 0000-0002-7507-1159
Saurabh SatijaSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India.ORCID 0000-0003-4702-6534
University of Technology Sydney · AULovely Professional University · INIMU University · MYUniversity of Petroleum and Energy Studies · INUniversity of Ulster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic respiratory disorders affect millions of people worldwide. Pathophysiological changes to the normal airway wall structure, including changes in the composition and organization of its cellular and molecular constituents, are referred to as airway remodeling. The inadequacy of effective treatment strategies and scarcity of novel therapies available for the treatment and management of chronic respiratory diseases have given rise to a serious impediment in the clinical management of such diseases. The progress made in advanced drug delivery, has offered additional advantages to fight against the emerging complications of airway remodeling. This review aims to address the gaps in current knowledge about airway remodeling, the relationships between remodeling, inflammation, clinical phenotypes and the significance of using novel drug delivery methods.

Indexed as

Airway RemodelingAdministration, InhalationAsthmaDrug CarriersHumansInflammationLungMedication AdherencePulmonary Disease, Chronic ObstructiveDrug CarriersCOPDNDDSremodelingrespiratory disorders

Identifiers

PMID35019757
PMCPMC8890134
OpenAlexW4205989633

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.